In this episode of DarshanTalks, you dive into what U.S. Food and Drug Administration (FDA) inspectors will demand when they show up on-site. You walk through the five critical documents every life-sciences or pharma company should have ready, because without them, an inspection can become a deal-breaker fast.

You stress that compliance isn’t just paperwork; it’s the backbone of long-term viability. A weak document trail, sloppy record-keeping, or missing records can lead to penalties, regulatory exposure, or even shutdowns. Tight compliance and strong documentation aren’t optional. They’re deal insurance.

The episode gives concrete guidance on what to have in place before regulators knock. It’s essential listening for executives, compliance officers, and M&A advisors in biotech, pharma, and medical device businesses.

Support the show

www.kulkarnilawfirm.com